Approval · Notice of Compliance 19679 · 2017
REACTINE RAPID DISSOLVE: Notice of Compliance 19679
Issued August 18, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19679
- Date
- August 18, 2017
- Company
- McNeil Consumer Healthcare, division of Johnson & Johnson Inc.Markham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REACTINE RAPID DISSOLVE | 02467577 | Marketed |
Medicinal ingredients
- CETIRIZINE HYDROCHLORIDE 10 MG per TAB